Statistics about Health, Pharma & Medtech in United States
Statistics
- Oncternal Therapeutics, Inc. liabilities 2022-2023
- Upexi, Inc. operating profit 2020-2023
- Trevi Therapeutics total equity 2019-2023
- Biocept Inc operating profit 2018-2022
- Tyra Biosciences total equity 2019-2023
- Travere Therapeutics, Inc. total equity 2019-2023
- Vaccinex liabilities 2019-2023
- Organogenesis Holdings net income 2019-2023
- Biocept Inc gross profit 2013-2014
- Biora Therapeutics, Inc. total equity 2019-2023
- Brainstorm Cell Therapeutics total equity 2019-2023
- Oncotelic Therapeutics, Inc. operating profit 2019-2023
- Outlook Therapeutics, Inc. net income 2015-2016
- Relay Therapeutics total assets 2019-2023
- Oncotelic Therapeutics, Inc. net income 2019-2023
- Unicycive Therapeutics operating profit 2020-2023
- Brainstorm Cell Therapeutics operating profit 2019-2023
- Brainstorm Cell Therapeutics net cash 2019-2023
- Usana Health Sciences operating profit 2019-2023
- Revolution Medicines operating profit 2019-2023
- Brainstorm Cell Therapeutics total assets 2019-2023
- Twist Bioscience total equity 2019-2023
- Revance Therapeutics revenue 2019-2023
- Sab Biotherapeutics, Inc. revenue 2020-2023
- Orgenesis net income 2019-2023
- Revolution Medicines revenue 2019-2023
- Outlook Therapeutics, Inc. operating profit 2019-2023
- Ontrak, Inc. operating profit 2019-2023
- Biocept Inc liabilities 2018-2022
- Biocept Inc net income 2019-2022
- Biocept Inc revenue 2018-2022
- Biora Therapeutics, Inc. gross profit 2019-2021
- Ovid Therapeutics operating profit 2019-2023
- Revance Therapeutics operating profit 2019-2023
- United Therapeutics liabilities 2019-2023
- Biora Therapeutics, Inc. net income 2019-2022
- Odonate Therapeutics, Inc. net cash 2017-2020
- Avidity Biosciences net cash 2019-2023
- Avidity Biosciences liabilities 2019-2023
- Avidity Biosciences net income 2019-2023
- Avidity Biosciences revenue 2019-2023
- Oncocyte net cash 2019-2023
- Avidity Biosciences operating profit 2019-2023
- Renovorx liabilities 2020-2023
- Ocuphire Pharma, Inc. net cash 2019-2023
- Ocugen net cash 2019-2023
- Vaccinex net cash 2019-2023
- Unicycive Therapeutics total assets 2020-2023
- Dermata Therapeutics total equity 2019-2023
- Dermata Therapeutics liabilities 2020-2023
- Dermata Therapeutics operating profit 2020-2023
- Enanta Pharmaceuticals revenue 2019-2023
- Dermata Therapeutics total assets 2020-2023
- Dermata Therapeutics net cash 2020-2023
- Odonate Therapeutics, Inc. liabilities 2017-2020
- Oncocyte liabilities 2019-2023
- Enanta Pharmaceuticals liabilities 2019-2023
- Avidity Biosciences total equity 2019-2023
- Avidity Biosciences total assets 2019-2023
- One World Products, Inc. operating profit 2019-2023
- United Therapeutics net income 2015-2019
- Renovorx net cash 2020-2023
- Odonate Therapeutics, Inc. total equity 2016-2020
- Ocuphire Pharma, Inc. total equity 2019-2023
- Rezolute operating profit 2020-2024
- Oncocyte total equity 2019-2023
- Dyne Therapeutics total equity 2019-2023
- Ocugen total equity 2019-2023
- Unicycive Therapeutics net cash 2020-2023
- Relay Therapeutics net cash 2019-2023
- Dyne Therapeutics net cash 2019-2023
- Ocugen total assets 2019-2023
- Dyne Therapeutics liabilities 2019-2023
- Dyne Therapeutics total assets 2019-2023
- Dyne Therapeutics net income 2019-2023
- Odonate Therapeutics, Inc. total assets 2017-2020
- Dyne Therapeutics operating profit 2019-2023
- Regulus Therapeutics net cash 2019-2023
- Oncocyte total assets 2019-2023
- Ocuphire Pharma, Inc. total assets 2019-2023
- Regen Biopharma net cash 2019-2023
- Usana Health Sciences net cash 2019-2023
- One World Products, Inc. net income 2015-2019
- Biora Therapeutics, Inc. liabilities 2019-2023
- Biocept Inc total assets 2018-2022
- Outlook Therapeutics, Inc. revenue 2015-2019
- Biodelivery Sciences International Inc net cash 2017-2021
- Oncternal Therapeutics, Inc. operating profit 2019-2023
- Biodelivery Sciences International Inc total assets 2017-2021
- Biodelivery Sciences International Inc operating profit 2017-2021
- Olema Pharmaceuticals operating profit 2019-2023
- Biodelivery Sciences International Inc liabilities 2017-2021
- Upexi, Inc. total assets 2020-2023
- Biodesix net income 2019-2023
- Eagle Pharmaceuticals total equity 2018-2022
- Relay Therapeutics total equity 2019-2023
- Ontrak, Inc. revenue 2019-2023
- Biodelivery Sciences International Inc total equity 2017-2021
- Eagle Pharmaceuticals liabilities 2018-2022
- Eagle Pharmaceuticals operating profit 2018-2022